Pattern | Drugs resistance pattern (Antibiogram) | No. of drug to which strains were resistant | No. of MDR strains (%) |
---|---|---|---|
I | AMP:PEN:CEFA:VAN:TET | 5 | 3/29 (10.3%) |
II | AMP:PEN:CEFA:CLN:TET | 5 | 2/29 (6.9%) |
III | AMP:PEN:CEFA:CHL:TET | 5 | 1/29 (3.4%) |
IV | AMP:PEN:CLN:CRO:TET | 5 | 1/29 (3.4%) |
V | AMP:CEFA:CLN:CRO:TET | 5 | 1/29 (3.4%) |
VI | PEN:CEFA:CLN:CRO:TET | 5 | 1/29 (3.4%) |
VII | CEFA:ERY:CLN:CHL:TET | 5 | 1/29 (3.4%) |
VIII | AMP:PEN:CEFA:ERY:CRO:TET | 6 | 1/29 (3.4%) |
IX | AMP:PEN:CEFA:CLN:CRO:TET | 6 | 1/29 (3.4%) |
X | PEN:CEFA:CLN:CHL:CRO:TET | 6 | 1/29 (3.4%) |
XI | PEN:ERY:CLN:CHL:CRO:TET | 6 | 1/29 (3.4%) |
XII | CEFA:ERY:CLN:CHL:CRO:TET | 6 | 1/29 (3.4%) |
XIII | AMP:PEN:CEFA:VAN:ERY:CLN:TET | 7 | 3/29 (10.3%) |
XIV | AMP:PEN:CEFA:VAN:CLN:CRO:TET | 7 | 1/29 (3.4%) |
XV | AMP:PEN:CEFA:ERY:CLN:CRO:TET | 7 | 1/29 (3.4%) |
XVI | AMP:PEN:CEFA:VAN:CHL:CRO:TET | 7 | 1/29 (3.4%) |
XVII | AMP:PEN:CEFA:CLN:CHL:CRO:TET | 7 | 1/29 (3.4%) |
XVIII | AMP:PEN:CEFA:VAN:CLN:CHL:CRO:TET | 8 | 3/29 (10.3%) |
XXIV | AMP:PEN:CEFA:ERY:CLN:CHL:CRO:TET | 8 | 2/29 (6.9%) |
XXX | AMP:PEN:CEFA:VAN:ERY:CLN:CHL:TET | 8 | 1/29 (3.4%) |
XXXI | AMP:PEN:CEFA:VAN:ERY:CLN:CHL:CRO:TET | 9 | 1/29 (3.4%) |